Navigation Links
New Treatment Against Osteoarthritis: Orthokine Therapy Highly Effective Against Knee Arthritis After Two Years
Date:2/23/2009

DÿSSELDORF, Germany, February 23 /PRNewswire/ -- An international team of researchers has evaluated the effectiveness of Orthokine therapy for osteoarthritis of the knee, and the results have been published in the February edition of the specialist journal "Osteoarthritis and Cartilage". The researchers followed 376 patients to determine the effectiveness of various osteoarthritis treatments. After six months as well as after two years, patients who received Orthokine therapy experienced significantly less pain and more improved joint function than those who received hyaluronic acid or a placebo. Orthokine therapy is a biotechnology-based method in which proteins that inhibit inflammation are obtained from the patient's own blood and injected into the affected joint.

"In this study and for several thousand patients whom we have treated, Orthokine has proven an extraordinarily safe and effective way of treating osteoarthritis of the knee. I am delighted that distinguished experts have now confirmed these findings," said Dr. Peter Wehling, CEO of ORTHOGEN AG, in Düsseldorf on February 21. "We are now planning to distribute the IP-protected Orthokine technology world- wide. Orthokine is already being distributed in various EU countries through ORTHOGEN or other distributors."

Orthokine is the first scientifically proven, placebo-controlled autologous therapy in the orthopaedic field.

This kind of therapy was recently discussed in The New York Times. Two of the Pittsburgh Steelers' biggest stars, Hines Ward and Troy Polamalu, used their own blood cells in an innovative injury treatment before winning the Super Bowl.

    To find out more:
   http://www.oarsijournal.com/
   http://www.oarsi.org

    For more information please contact:
    Orthogen AG
    Press and 
'/>"/>
SOURCE  Orthogen AG
Copyright©2009 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 

Related medicine technology :

1. Breast Cancer Patients May Have a New Treatment Option When Cancer Spreads
2. American Heart Association EMS Survey Uncovers Deficiencies in Response, Treatment and Transfer of Patients With Most Deadly Heart Attacks
3. Inspiration Biopharmaceuticals, Inc. Initiates Phase 1 Clinical Trial of IB1001 for the Treatment of Hemophilia B
4. Study Suggests New Treatment Approach May be Needed for Management of Depression in Some People With Bipolar Disorder
5. Endo Pharmaceuticals Announces Research Collaborations to Develop Novel Pain Treatments and Discover Potential Cancer Treatments
6. Nplate(R) Approved in the European Union for the Treatment of Chronic Immune (Idiopathic) Thrombocytopenic Purpura (ITP)
7. Idenix Pharmaceuticals and GlaxoSmithKline Sign Worldwide License Agreement for IDX899, a Novel NNRTI for the Treatment of HIV
8. Positive Data From Lung Study May Lead to First FDA Approved Treatment for Pulmonary Fibrosis
9. FDA Grants Priority Review of a Supplemental Biologics License Application for Cinryze(TM) C1 Inhibitor (Human) as Treatment for Acute Attacks of Hereditary Angioedema (HAE)
10. Cerenis Therapeutics In-Licenses Intellectual Property for New Treatment of Aortic Valve Stenosis
11. Medgenics Announces Positive Data From Phase I/II Clinical Trial of EPODURE Treatment of Anemia in Chronic Kidney Disease
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/17/2013)... , May 17, 2013 Fuse Science, Inc. (OTCQB: ... company that is developing new, patent-pending technologies poised to redefine ... that it will hold a business update teleconference and webcast ... nd , 2013 at 4:30 PM ET. ... will host the call and will be joined by ...
(Date:5/17/2013)... 2013  PENTAX Medical, a healthcare industry leader ... leader in ultrasound imaging, recently announced renewed collaborative ... further innovation in the development of Endoscopic Ultrasound ... and PENTAX Medical endoscopic portfolio have formed one ... systems. This agreement will continue to grow their ...
(Date:5/17/2013)... -- Sanofi (EURONEXT: SAN and NYSE: SNY ) announced ... , examining the selective JAK2 inhibitor SAR302503 for myelofibrosis ... The primary endpoint assessed the proportion of patients achieving ... in previous trials, the most common adverse events were ... presented at an upcoming medical congress. ...
Breaking Medicine Technology:Fuse Science, Inc. to Hold Business Update Webcast and Teleconference on May 22nd 2PENTAX Medical And Hitachi-Aloka Medical Continue Joint Innovation And Global Leadership In Endoscopic Ultrasound Systems 2PENTAX Medical And Hitachi-Aloka Medical Continue Joint Innovation And Global Leadership In Endoscopic Ultrasound Systems 3Sanofi Reports Positive Topline Results from Pivotal Phase III JAKARTA Study for JAK2 Inhibitor in Myelofibrosis 2Sanofi Reports Positive Topline Results from Pivotal Phase III JAKARTA Study for JAK2 Inhibitor in Myelofibrosis 3Sanofi Reports Positive Topline Results from Pivotal Phase III JAKARTA Study for JAK2 Inhibitor in Myelofibrosis 4Sanofi Reports Positive Topline Results from Pivotal Phase III JAKARTA Study for JAK2 Inhibitor in Myelofibrosis 5Sanofi Reports Positive Topline Results from Pivotal Phase III JAKARTA Study for JAK2 Inhibitor in Myelofibrosis 6
(Date:5/17/2013)... HealthDay Reporter , , FRIDAY, May 17 (HealthDay News) ... brain may make the call on which ear you ... The dominant side of your brain is where your ... human population is left-brain dominant, and those people tend ... who are right-brain dominant. In this study, scientists found ...
(Date:5/17/2013)... 17, 2013 Fighting addiction is hard ... for diabetics, treatment is more difficult and complicated. Drug ... to monitor blood sugar levels and administer insulin when ... drug rehab for diabetics needs to have ... needs of the diabetic, and has experience caring for ...
(Date:5/17/2013)... 17 (HealthDay News) -- Teen bullies are more likely ... finds. UT Dallas researchers analyzed several decades of ... All of them had similar working-class backgrounds and most ... were in their mid-50s. Nearly half of the ... years engaged in some form of criminal activity -- ...
(Date:5/17/2013)... SportsFanPlayground.com is currently offering a new ... $319.99, nearly 20% off of the retail price. , The ... Adventures and Carnival Games, and a complementary 3-month Xbox Live ... Kinect Star Wars Bundle available for shipping. The Star Wars bundle ... 360 console, a custom white Kinect sensor, an Xbox 360 wired ...
(Date:5/17/2013)... Guide to the DSM-5 explores all revisions to ... Manual, and shows clinicians how they can best ... most contentious resource. Written by a celebrated professor ... and new research to point out where DSM-5 ... the jury,s still out. Along the way, The ...
Breaking Medicine News(10 mins):Health News:Cellphone Use May Reveal Your 'Dominant Brain' 2Health News:Cellphone Use May Reveal Your 'Dominant Brain' 3Health News:Above It All Treatment Center Helps Drug Addicts who are Type I and Type II Diabetics 2Health News:Above It All Treatment Center Helps Drug Addicts who are Type I and Type II Diabetics 3Health News:Xbox 360 Kinect Bundle 20% Off at SportsFanPlayground.com 2
... are banned for manufacture, import and use in India. ... use in the country but their manufacture is allowed ... to Information (RTI) Act. ,As India grapples ... productivity and environmental safety, the government has also acknowledged ...
... Manipur are literally holding the state to ransom with ... huge extortion notices slapped by rebels. ,Pharmacies ... until Sunday after a rebel group demanded Rs.10 million ... Association and the All Manipur Pharmaceutical and Druggists Association. ...
... poison that can kill, arsenic also can prolong the lives ... new study out Saturday found. ,"This study shows ... earlier in the course of treatment," said Dr. Bayard Powell, ... and the lead author of the research delivered at the ...
... The last two decades have seen modest overall improvements in ... However, according to researchers at The University of Texas M. ... the rates for black women; differences in life expectancy between ... study, presented today (June 3) at the 43rd annual American ...
... the journal Health Psychology, by the American Psychological Association ... or mean disposition tend to have compromised lung ... were ruled out as possible causes of lung dysfunction. ... White 18-30 year olds from four metropolitan areas (sampled ...
... new study co-led by an urologist and a radiation ... specialty of the physician patients see can influence ... analyzed men with localized prostate cancer. It found that ... urologist are more likely to undergo surgery to remove ...
Cached Medicine News:Health News:25 Pesticides Banned in India, Others Face Partial Curbs 2Health News:Manipur Pharmacies Shut Down Fearing Separatist Threats 2Health News:Advanced Breast Cancer: Study Reveals White and Black Women Have Different Survival Rates 2Health News:Unhealthy Lungs Linked to Hostility? 2Health News:Early Prostate Cancer: Specialty of Physician Influences Type of Therapy Received 2Health News:Early Prostate Cancer: Specialty of Physician Influences Type of Therapy Received 3
Patient-Centered Therapy that promotes natural cardiac function....
... The Alliance Catheter Delivery ... manipulation, and stabilization of the ... Alliance CDS has a patented ... for quick and easy access ...
... throughout the world are facing difficult times ... of the blood supply in the face ... donor base. Clearly, these centers must find ... manage their existing donor pools, and to ...
The COBE 2991 Cell Processor provides reliable, automated cell processing, with the control you need to get reproducible results in your lab. This versatile machine offers users reliability and multi...
Medicine Products: